Mutual of America Capital Management LLC Trims Stock Position in HealthEquity, Inc. (NASDAQ:HQY)

Mutual of America Capital Management LLC trimmed its stake in HealthEquity, Inc. (NASDAQ:HQY) by 1.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 96,159 shares of the company’s stock after selling 1,559 shares during the quarter. Mutual of America Capital Management LLC’s holdings in HealthEquity were worth $9,226,000 at the end of the most recent quarter.

Other institutional investors have also recently modified their holdings of the company. Holocene Advisors LP purchased a new position in HealthEquity in the 3rd quarter worth approximately $1,246,000. GSA Capital Partners LLP purchased a new position in shares of HealthEquity in the third quarter worth $638,000. Natixis Advisors LLC raised its stake in shares of HealthEquity by 29.8% in the third quarter. Natixis Advisors LLC now owns 209,175 shares of the company’s stock worth $17,122,000 after purchasing an additional 48,009 shares during the last quarter. Vaughan Nelson Investment Management L.P. lifted its holdings in shares of HealthEquity by 36.7% during the third quarter. Vaughan Nelson Investment Management L.P. now owns 843,423 shares of the company’s stock valued at $69,034,000 after purchasing an additional 226,563 shares in the last quarter. Finally, Loomis Sayles & Co. L P boosted its position in shares of HealthEquity by 2.2% during the third quarter. Loomis Sayles & Co. L P now owns 1,126,645 shares of the company’s stock valued at $92,216,000 after buying an additional 24,665 shares during the last quarter. 99.55% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on HQY. Royal Bank of Canada upped their target price on shares of HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research note on Tuesday, December 10th. The Goldman Sachs Group initiated coverage on shares of HealthEquity in a report on Friday, November 15th. They issued a “neutral” rating and a $108.00 target price on the stock. Barrington Research boosted their target price on shares of HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research note on Monday, December 2nd. JMP Securities raised their price target on HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a research note on Tuesday, December 10th. Finally, Mizuho initiated coverage on HealthEquity in a research report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 price objective for the company. One analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $113.54.

Insider Activity at HealthEquity

In related news, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the sale, the director now owns 78,219 shares of the company’s stock, valued at approximately $8,704,992.51. This trade represents a 6.85 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Stuart B. Parker sold 25,000 shares of the company’s stock in a transaction that occurred on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the completion of the transaction, the director now owns 19,061 shares of the company’s stock, valued at $1,843,579.92. The trade was a 56.74 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 39,000 shares of company stock worth $3,895,788. 2.20% of the stock is owned by corporate insiders.

HealthEquity Stock Performance

Shares of HQY opened at $109.76 on Friday. The business has a 50-day simple moving average of $105.13 and a two-hundred day simple moving average of $93.51. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. HealthEquity, Inc. has a 52 week low of $65.01 and a 52 week high of $115.59. The stock has a market cap of $9.51 billion, a price-to-earnings ratio of 100.70, a PEG ratio of 1.60 and a beta of 0.55.

HealthEquity (NASDAQ:HQY) last released its earnings results on Monday, December 9th. The company reported $0.59 EPS for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same quarter in the prior year, the firm posted $0.40 EPS. On average, analysts expect that HealthEquity, Inc. will post 2.32 EPS for the current year.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.